ipamorelin clinical trial 2025 European Society for Medical Oncology (ESMO) Annual Congress: Presentation of Subgroup Analysis Results from the Phase II of Nanvuranlat Suggesting Patient Selection Criteria for the Global Phase III Clinical Selection:90 Capsules Immune & Wellness Week 1 — GHK-Cu

ipamorelin clinical trial 2025 European Society for Medical Oncology (ESMO) Annual Congress: Presentation of Subgroup Analysis Results from the Phase II of Nanvuranlat Suggesting Patient Selection Criteria for the Global Phase III Clinical Selection:90 Capsules Immune & Wellness Week 1 — GHK-Cu

Week 1 — GHK-Cu scalp protocol. Noticed subtle changes in hair texture and appearance already. Tracking progression weekly. #GHKCu #HairGrowthJourney #ScalpHealth #Biohacking #hairexperiment

Neither oral Minoxidil nor GHK-Cu is recommended during pregnancy or breastfeeding

Immune & Wellness

Selection:90 Capsules

Informed Sport certified